Testimonial: From Research to International Recognition
Supported by GERCA, Walaa Fakih completed her PhD on atrial fibrillation in Strasbourg, achieved significant advancements, and presented her findings at international scientific conferences.
Testimonial: GERCA Supports Thesis on Aortic Stenosis
A study at Strasbourg University Hospital has unveiled new insights into aortic stenosis mechanisms, identifying potential therapeutic targets for France's most common heart valve disease. This research, made possible through GERCA's support, could pave the way for medical treatments that might help patients avoid surgical intervention.
Testimonial: a Chinese-French collaboration enabled by GERCA
GERCA’s support enabled research on septic cardiovascular dysfunction, a life-threatening condition with high mortality rates. The research, conducted in Strasbourg, investigated the role of SGLT2 and its inhibitor, empagliflozin, in treating the condition. This research not only advances treatment but also fosters collaboration between China and France in medical research.
Testimonial: a Japanese-French collaboration enabled by GERCA
Kensuke Matsushita, a cardiologist, highlights his research in structural heart disease and COVID-19-related cardiovascular disease. He expresses gratitude for the support he received during his doctoral studies at the University of Strasbourg, emphasizing the importance of preserving opportunities for international scientific exchanges.
Testimonial: a Vietnamese-French Collaboration
A Vietnamese researcher, supported by GERCA, is advancing critical research on rheumatic mitral valve stenosis—a condition causing 1.4 million deaths annually. With GERCA’s funding, their study explores innovative therapies like Empagliflozin, bridging collaboration between Vietnam and France to tackle health inequities in underserved regions.